Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
my mhealth and University of Southampton announced as Round 2 Winner of The Artificial Intelligence in Health and Care Award
my mhealth Limited and the University of Southampton have been announced as a winner of […]
Artificial Intelligence Breast Cancer Screening Project Wins Government Funding for NHS Trial
UK researchers have secured government funding to study the use of artificial intelligence (AI) for breast cancer screening in […]
Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive
Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]
Over One Million Jabs Booked as NHS Vaccine Programme Opens to All Adults
More than one million jab appointments were booked since the NHS vaccination programme opened for […]
£36 Million Boost for AI Technologies to Revolutionise NHS Care
New technology will help detect cancers and provide mental health support Projects are part of […]
Qure.ai ’s Brain CT AI Wins Funding from the NHS
The UK Department of Health and Social Care announced that Qure.ai has been selected as […]
Sir Richard Sykes Appointed Chair of Vaccine Taskforce
Sir Richard will use his extensive experience in biotechnology and pharmaceuticals to lead the significant […]
NHS Digital Terminology Server Goes Live
NHS Digital’s Terminology Server, a solution which enables healthcare IT systems to speak the same […]
NHS Ahead of Target in Recovery of Elective Care, and Mental Health Services Back to Pre-pandemic Levels
Operations and other routine care are ahead of ambitions set out in April with mental […]
Half a Million COVID Jabs Booked in ‘Glastonbury Rush’ This Morning
The NHS saw a welcome surge in demand for vaccines this morning as half a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more